CL2012001548A1 - Composicion nutricional que comprende el probiotico bifidobacterium lactis con registro cncm i-3446 y membrana del globulo graso de la leche (mfgm). - Google Patents

Composicion nutricional que comprende el probiotico bifidobacterium lactis con registro cncm i-3446 y membrana del globulo graso de la leche (mfgm).

Info

Publication number
CL2012001548A1
CL2012001548A1 CL2012001548A CL2012001548A CL2012001548A1 CL 2012001548 A1 CL2012001548 A1 CL 2012001548A1 CL 2012001548 A CL2012001548 A CL 2012001548A CL 2012001548 A CL2012001548 A CL 2012001548A CL 2012001548 A1 CL2012001548 A1 CL 2012001548A1
Authority
CL
Chile
Prior art keywords
mfgm
nutritional composition
milk fat
cncm
record
Prior art date
Application number
CL2012001548A
Other languages
English (en)
Inventor
Jalil Benyacoub
Anne Donnet-Hughes
Mohamed Nabil Bosco
Stéphanie Blum-Sperisen
Eduardo Schiffrin
Laurent Favre
Isabelle Bureau-Franz
Lionel Jean René Bovetto
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2012001548A1 publication Critical patent/CL2012001548A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C2240/00Use or particular additives or ingredients
    • A23C2240/05Milk products enriched with milk fat globule membrane
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PROPONE UNA COMPOSICIÓN NUTRICIONAL QUE COMPRENDE UN PROBIÓTICO Y MEMBRANA DEL GLÓBULO GRASO DE LA LECHE (MFGM) DONDE LA MFGM Y LOS PROBIÓTICOS POTENCIAN MUTUAMENTE SUS RESPECTIVOS<br /> EFECTOS Y PROMUEVEN LOS MECANISMOS PROTECTORES BENEFICIOSOS COMPLEMENTARIOS QUE REFLEJAN UNA SINERGIA FISIOLÓGICA. LA COMPOSICIÓN NUTRICIONAL PUEDE SER UNA FÓRMULA INFANTIL, CEREALES INFANTILES, ALIMENTO PARA BEBÉS O UN PRODUCTO NUTRICIONAL PARA EL CUIDADO DE LA SALUD. EL EFECTO SINÉRGICO PUEDE INCLUIR PROMOVER LA MADURACIÓN INMUNE Y/O LA EDUCACIÓN INMUNE Y/O REDUCIR LA INFLAMACIÓN Y/O TRATAR O PREVENIR UNA ENFERMEDAD O INFECCIONES.<br />  
CL2012001548A 2009-12-08 2012-06-08 Composicion nutricional que comprende el probiotico bifidobacterium lactis con registro cncm i-3446 y membrana del globulo graso de la leche (mfgm). CL2012001548A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09178339 2009-12-08

Publications (1)

Publication Number Publication Date
CL2012001548A1 true CL2012001548A1 (es) 2012-09-14

Family

ID=42040660

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012001548A CL2012001548A1 (es) 2009-12-08 2012-06-08 Composicion nutricional que comprende el probiotico bifidobacterium lactis con registro cncm i-3446 y membrana del globulo graso de la leche (mfgm).

Country Status (12)

Country Link
US (1) US9226521B2 (es)
EP (1) EP2509429A1 (es)
CN (1) CN102665428A (es)
AU (1) AU2010329990B2 (es)
BR (1) BR112012013766A2 (es)
CA (1) CA2783768A1 (es)
CL (1) CL2012001548A1 (es)
MX (1) MX2012006640A (es)
PH (1) PH12012501050A1 (es)
RU (1) RU2563355C2 (es)
TW (1) TW201143633A (es)
WO (1) WO2011069987A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10576110B2 (en) 2009-05-11 2020-03-03 Societe Des Produits Nestle S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
CN101978841B (zh) * 2010-08-31 2013-04-10 浙江贝因美科工贸股份有限公司 一种抗蛋白过敏及营养婴儿配方奶粉
CA2836241A1 (en) * 2011-06-08 2012-12-13 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
US20140170126A1 (en) * 2011-07-12 2014-06-19 Nestec S.A. Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs
FR2978647B1 (fr) 2011-08-01 2013-08-16 Groupe Lactalis Melange proteique fonctionnel et stable pour compositions alimentaires destinees aux personnes necessitant une amelioration et un maintien de leur condition physique.
US20140107193A1 (en) * 2011-10-14 2014-04-17 Mead Johnson Nutrition Company Nutritional composition containing a neurologic component of kaempferol and/or fisetin and uses thereof
PL2768313T3 (pl) * 2011-10-18 2016-02-29 Nestec Sa Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie
CN104822277A (zh) * 2012-11-29 2015-08-05 雀巢产品技术援助有限公司 合生元组合物及其用途
WO2014099134A1 (en) * 2012-12-18 2014-06-26 Mjn U.S. Holdings Llc Milk-based nutritional compositions containing lactoferrin and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9661874B2 (en) * 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9980506B2 (en) 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
SE537951C2 (sv) * 2013-07-01 2015-12-01 Hero Ag Profylaktisk användning av modersmjölksersättning mot otit
US9226914B2 (en) * 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
EP3021942A4 (en) * 2013-07-19 2017-04-19 The Regents of The University of California Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20150119322A1 (en) * 2013-07-31 2015-04-30 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
ES2683190T3 (es) * 2013-08-09 2018-09-25 Ab-Biotics S.A. Probiótico para el llanto infantil excesivo
US20150164833A1 (en) * 2013-12-17 2015-06-18 Mead Johnson Nutrition Company Nutritional composition containing a neurologic component of ursolic acid and uses thereof
WO2015091789A2 (en) * 2013-12-19 2015-06-25 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
CN104187313A (zh) * 2014-07-24 2014-12-10 梁艳红 一种营养助消化的1段婴幼儿米粉
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
CN106556662A (zh) * 2015-12-17 2017-04-05 中国医科大学 可实现羊血清白蛋白鉴定及绝对定量的试剂盒及测定方法
CN106359604B (zh) * 2016-08-24 2019-06-18 北京三元食品股份有限公司 一种促进肠道健康的婴儿配方乳粉及其制备方法
US20180133287A1 (en) * 2016-11-14 2018-05-17 Mead Johnson Nutrition Company Nutritional compositions providing dietary management of colic
CN106578134A (zh) * 2016-12-31 2017-04-26 东北农业大学 一种预防感染性腹泻的婴儿配方奶粉
IL269546B (en) 2017-03-27 2022-07-01 Biogaia Ab Lactic acid bacteria, methods and uses thereof
CN107156302A (zh) * 2017-04-17 2017-09-15 南昌大学 一种含乳脂肪球膜的婴幼儿配方奶粉及制备方法
US11197917B2 (en) * 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN107927198A (zh) * 2017-12-19 2018-04-20 光明乳业股份有限公司 一种用于早产儿饮用奶粉及其制备方法
US20220088124A1 (en) * 2018-04-12 2022-03-24 Empire Biotechnologies, Inc. Compositions and methods for treating necrotizing enterocolitis
GB2573538B (en) * 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
US20210352925A1 (en) * 2019-02-04 2021-11-18 N.V. Nutricia Fermented formula with non digestible oligosaccharides for sleep improvement
CN109744446A (zh) * 2019-02-19 2019-05-14 杭州海王生物工程有限公司 一种含n-乙酰神经氨酸的乳清蛋白类固体饮料及其制备方法
EP4003035A4 (en) * 2019-07-26 2023-04-12 Infinant Health, Inc NUTRITIONAL COMPOSITIONS WITH SECRETED IGA, COMPONENTS OF MEMBRANES OF MILK FAT GLOBULES AND/OR BIFIDOBACTERIUM
CN110810514A (zh) * 2019-11-25 2020-02-21 海南国健高科技乳业有限公司 一种儿童奶粉及其制备方法
GB2591983A (en) * 2019-12-04 2021-08-18 Mjn Us Holdings Llc Compositions and methods for preserving probiotic viability
CN113892649B (zh) * 2020-06-18 2024-07-09 湖南农业大学 一种益生菌微胶囊及其制备方法
CN111990461A (zh) * 2020-08-18 2020-11-27 北安宜品努卡乳业有限公司 一种增强免疫力的调制乳粉及其制备方法
CN112042750B (zh) * 2020-09-09 2022-04-05 北京三元食品股份有限公司 一种富含乳脂肪球膜蛋白、磷脂和低聚糖的婴幼儿配方奶粉及其制备方法
CN114586986A (zh) * 2020-12-07 2022-06-07 黑龙江飞鹤乳业有限公司 一种益智营养组分
CN115191604B (zh) * 2021-07-27 2024-07-12 黑龙江飞鹤乳业有限公司 一种营养组合物和包含营养组合物的食品及应用
EP4408199A1 (en) * 2021-09-28 2024-08-07 Société des Produits Nestlé S.A. Compositions for use
GB2620601A (en) * 2022-07-13 2024-01-17 Mjn Us Holdings Llc Use of milk fat globule membrane
CN115989836A (zh) * 2022-11-29 2023-04-21 黑龙江飞鹤乳业有限公司 含乳铁蛋白和益生菌的营养组合物、食品及用途
CN115997937B (zh) * 2022-12-13 2024-03-12 黑龙江飞鹤乳业有限公司 含有乳脂肪球膜的营养组合物、用途及食品
WO2024243008A1 (en) * 2023-05-19 2024-11-28 Ohio State Innovation Foundation Compositions and methods of making and use thereof
CN116616348B (zh) * 2023-07-21 2023-11-14 美赞臣婴幼儿营养品技术(广州)有限公司 含唾液酸的组合物及其在益生菌增殖和调节免疫中的应用
WO2025196273A1 (en) 2024-03-22 2025-09-25 Dsm Ip Assets B.V. Combination of mixtures of hmos with mfgm and their use
WO2025196272A1 (en) 2024-03-22 2025-09-25 Dsm Ip Assets B.V. Combination of mixtures of hmos with mfgm and their use
WO2025233458A1 (en) * 2024-05-08 2025-11-13 N.V. Nutricia Nutritional composition for strenghtening the gut barrier
WO2025233457A1 (en) 2024-05-08 2025-11-13 N.V. Nutricia Nutritional composition comprising a probiotic
WO2025233459A1 (en) * 2024-05-08 2025-11-13 N.V. Nutricia Nutritional composition for preventing intestinal barrier disruption
CN119453143A (zh) * 2024-11-13 2025-02-18 扬州大学 肠道四界菌群稳定的动物模型的构建方法及其在评价婴配粉的免疫调节功能中的应用
CN119817811B (zh) * 2025-03-17 2025-06-10 内蒙古蒙牛乳业(集团)股份有限公司 营养组合物及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
ATE84680T1 (de) 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
JPH0530942A (ja) * 1991-07-25 1993-02-09 Riyoushiyoku Kenkyukai 高分子の腸管透過性を制御する効果のある 飲食品及び医薬品
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
DE69219768T2 (de) 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US5635401A (en) * 1995-09-08 1997-06-03 Cornell Research Foundation, Inc. Method to detect hormone treatment in animals
EP1039892B1 (en) * 1997-02-21 2004-04-28 Abbott Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
UA30063A (uk) 1997-12-11 2000-11-15 Микола Олександрович Онопрієнко Спосіб раннього вирощування просапних культур
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
CA2371696C (en) 1999-04-29 2005-11-15 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
MXPA06015184A (es) * 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
CA2583704C (en) * 2004-10-12 2012-12-11 Katrina Fletcher Beta-serum dairy products, neutral lipid-depleted and/or polar lipid-enriched dairy products, and processes for their production
AU2006233918B2 (en) * 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
WO2007010977A1 (ja) * 2005-07-21 2007-01-25 Kabushiki Kaisha Yakult Honsha 新規ビフィドバクテリウム属細菌及びその利用
WO2007009187A1 (en) * 2005-07-22 2007-01-25 Tarac Technologies Pty Ltd Polyphenol and probiotic containing nutritional supplement
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
FR2908605A1 (fr) 2006-11-21 2008-05-23 Groupe Lactalis Utilisation d'un ingredient contenant un concentre de membranes de globules gras du lait,pour la fabrication d'un aliment,d'une boisson ou d'un supplement alimentaire destine a une indication impliquant la paroi intestinale
UA30063U (uk) * 2007-10-12 2008-02-11 Одесская Национальная Академия Пищевых Технологий Кисломолочний напій геродієтичного призначення
KR20100120169A (ko) * 2008-01-24 2010-11-12 네스텍 소시에테아노님 영양 성분을 담고 있는 캡슐 및 이 캡슐로부터 영양액을 전달하는 방법

Also Published As

Publication number Publication date
PH12012501050A1 (en) 2013-02-04
US9226521B2 (en) 2016-01-05
CA2783768A1 (en) 2011-06-16
RU2563355C2 (ru) 2015-09-20
MX2012006640A (es) 2012-06-25
EP2509429A1 (en) 2012-10-17
BR112012013766A2 (pt) 2015-09-15
RU2012128546A (ru) 2014-01-20
AU2010329990A1 (en) 2012-06-21
CN102665428A (zh) 2012-09-12
US20120321600A1 (en) 2012-12-20
AU2010329990B2 (en) 2015-07-16
WO2011069987A1 (en) 2011-06-16
TW201143633A (en) 2011-12-16

Similar Documents

Publication Publication Date Title
CL2012001548A1 (es) Composicion nutricional que comprende el probiotico bifidobacterium lactis con registro cncm i-3446 y membrana del globulo graso de la leche (mfgm).
BRPI1010637A2 (pt) suplementos nutricionais orais compreendendo probióticos
PH12019501025A1 (en) Natural compositions providing dietary management of colic
MX2022013835A (es) Produccion sinergica de butirato asociada con la complejidad de la mezcla de hmo para usar en infantes o niños pequeños en con fines de salud.
PH12014501749A1 (en) A nutritional composition comprising probiotics and improving sleep patterns
MX385648B (es) Composiciones nutritivas y formulas infantiles que comprenden bifidobacterium animalis ssp.lactis y, opcionalmente, una mezcla de oligosacaridos para inducir una microbiota intestinal cercana a la de un infante alimentado por lactancia materna.
MX2009009318A (es) Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
PH12019550208B1 (en) Hmos blends for use in infants or young children for health purposes
BR112012003633A2 (pt) &#34;composição nutricional que compreende cepas de bifidobacterium longum e reduz os sintomas de alergia alimentar, especialmente em bebês e crianças.&#34;
AR076862A1 (es) Microorganismos no replicantes y su efecto de refuerzo inmunologico. composicion. metodo para aumentar efectividad de probioticos
WO2010103140A3 (es) Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
MY165628A (en) Human milk oligosaccharides for modulating inflammation
NZ601141A (en) Nutritional formulas containing synbiotics
IN2012DN00878A (es)
MY166945A (en) Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
MY150657A (en) Reduction of risk of diarrhoea
MX2019011058A (es) Moleculas probioticas para reducir virulencia patogena.
MY177636A (en) Use of lactic acid bacteria to treat or prevent eczema
MY183171A (en) Composition containing bacterium belonging to genus lactobacillus
BR112015028164A2 (pt) probióticos e métodos de uso
RU2017122615A (ru) Применение пробиотиков для усиления мужской фертильности
MY174136A (en) Bacterium belonging to genus lactobacillus
West et al. Editorial Material: Transfer of Probiotic Bacteria From Mother to Child: A Matter of Strain Specificity? in JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, vol 61, issue 2, pp 157-158
Nayak et al. Probiotics in oral care.